Keyphrases
Acute Course
25%
Acute Phase
25%
Acute Treatment
50%
Antidepressants
50%
Application Test
25%
Cause of Disease
25%
Causes of Suicide
25%
Clinical Response
25%
Combination Pharmacotherapy
25%
Continuation ECT
75%
Disease Burden
50%
Dosing Schedule
25%
Failure to Maintain
25%
Focused Approach
25%
Functional Impairment
25%
Functional Outcome
50%
Geriatric Depression
25%
Geriatrics
50%
Hamilton Depression Rating Scale (HAM-D)
25%
Illness
25%
Improved Strategies
25%
Late-life Depression
75%
Lithium
25%
Mood Disorders
25%
Older Patients
25%
Overtreatment
25%
Patient-centered
50%
Pharmacotherapy
100%
Primary Outcome Measure
25%
Public Health Risk
25%
Quality of Life
25%
Randomized Clinical Trial
25%
Rapid Growth
25%
Re-emergence
25%
Relative Efficacy
25%
Remission
100%
Remitters
25%
Significant Risk Factors
25%
Successful Treatment
25%
Targeting Strategies
25%
Tolerability
50%
Treatment-resistant
25%
Venlafaxine
25%
Pharmacology, Toxicology and Pharmaceutical Science
Antidepressant
40%
Diseases
80%
Functional Disease
20%
Late Life Depression
80%
Mood Disorder
20%
Pharmacotherapy
100%
Randomized Clinical Trial
20%
Remission
100%
Tolerability
40%
Venlafaxine
20%
Medicine and Dentistry
Antidepressant
6%
Antidepressant Activity
6%
Combination Drug Therapy
6%
Depression of Geriatric
6%
Disease Burden
13%
Diseases
13%
Drug Therapy
26%
Electroconvulsive Therapy
100%
Functional Disease
6%
Geriatrics
13%
Hamilton Rating Scale for Depression
6%
Individualization
6%
Late Life Depression
20%
Mood Disorder
6%
Primary Outcome
6%
Public Health
6%
Quality of Life
6%
Randomized Clinical Trials
6%
Venlafaxine
6%